Skip to main content

Corteva Value Stock - Dividend - Research Selection

Corteva

ISIN: US22052L1044 , WKN: A2PKRR

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Corteva, Inc. provides agriculture products worldwide. The company develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. It also supplies products to the agricultural input industry that protect against weeds, insects and other pests, and diseases, as well as to enhance crop health. The company is based in Wilmington, Delaware. Corteva, Inc. operates independently of DowDuPont Inc. as of June 1, 2019.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Mission Produce's Blueberry Business: A Hidden Opportunity?

2026-09-21
AVO's expanding blueberry acreage in Peru could boost seasonal earnings, cash generation and diversification as newer plantings mature.

Vylor and Rainbow Crops Partner to Accelerate Development of Novel Gene-Edited Corn Traits

2026-09-21
Vylor, the advanced seed and genetics company that will spin off from Corteva on October 1, 2026, and Rainbow Crops, a Belgium-based spin off from VIB, have announced a collaboration to advance new corn traits using artificial intelligence (AI) and multiplex gene editing, which enables scientists to edit multiple genes in a cell simultaneously.

Corteva (CTVA) Bets On A Belgian Partner For Crop Protection’s Next Act

2026-09-19
On September 9, Corteva (NYSE:CTVA) and Belgium’s Globachem N.V. announced a definitive agreement to form a 50/50 joint venture aimed at developing and commercializing new crop protection products for farmers in Europe and the Americas. The timing matters. Corteva’s crop protection business is set to spin off as a standalone public company, Vylor, on October […]

Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target

2026-09-18
Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.

Zacks Industry Outlook Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole

2026-09-18
Corteva, Archer Daniels Midland, The Scotts Miracle-Gro, Mission Produce and Dole have been highlighted in this Industry Outlook article.

5 Agriculture Operations Stock Picks to Tap Long-Term Growth Trends

2026-09-17
The Agriculture - Operations industry is positioned to tap innovation, automation and shifting food demand despite persistent cost and commodity pressures. CTVA, ADM, SMG, AVO and DOLE look promising.

Did Chemours' (CC) US$455 Million PFAS Deal Just Reframe Its Long‑Term Liability Narrative?

2026-09-17
On September 9, 2026, Chemours, DuPont, and Corteva reached a settlement with North Carolina and 11 nearby local entities, agreeing to pay US$455 million over 15 years to resolve PFAS-related claims tied to Chemours’ Fayetteville Works facility and other contamination issues. The agreement not only clears a significant portion of Chemours’ legacy PFAS exposure but also introduces a shared, net-present-value framework under the companies’ existing US$4.00 billion cost-sharing cap, potentially...

Citigroup Maintains Neutral on Corteva, Raises Price Target to $91

2026-09-17
Citigroup analyst Patrick Cunningham maintains Corteva (NYSE:CTVA) with a Neutral and raises the price target from $86 to $91.

DOLE vs. CTVA: Which Stock Is the Better Value Option?

2026-09-16
DOLE vs. CTVA: Which Stock Is the Better Value Option?

Corteva, Inc. (CTVA) Analyst/Investor Day Transcript

2026-09-16
Corteva, Inc. (CTVA) Analyst/Investor Day September 15, 2026 9:00 AM EDTCompany ParticipantsKimberly Booth - Vice President of Investor RelationsCharles...